Similar to results with CIBERSORT, high levels of CD8+ T cells early-stage CRC were associated with significantly poor outcome in individuals with early-stage CRC (HR = 5.0638, 95% CI [1.9554-13.1134], p = 0.0045), as shown in Figure 5B. This evidence concerns the gene CD8A and colorectal carcinoma.